title: Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers.
abstract: Tumor cells release membranous structures, defined as microvesicles or exosomes, consisting of an array of macromolecules derived from the originating cells, including proteins, lipids, and RNA. The expression of antigenic molecules recognizable by T cells originally suggested a role for these vesicles as a cell-free antigen source for anti-cancer vaccines; however, evidence demonstrates that tumor exosomes can exert a broad array of detrimental effects on the immune system - ranging from apoptosis of activated cytotoxic T cells to impairment of monocyte differentiation into dendritic cells, to induction of myeloid-suppressive cells. Immunosuppressive exosomes of tumor origin can be found in neoplastic lesions and biologic fluids from cancer patients, implying a potential role of these pathways in in vivo tumor progression and systemic paraneoplastic syndromes. Through the expression of molecules involved in angiogenesis promotion, stromal remodeling, signaling pathway activation through growth factor/receptor transfer, chemoresistance, and intercellular genetic exchange, tumor exosomes could represent a central mediator of the tumor microenvironment. Their release by tumor cells may represent the future for targeting therapeutic interventions and for development of multiplexed diagnostic biomarkers.
authors: James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.
authors: Carolyn D
authors: CD
authors: Roberson
authors: Safinur
authors: S
authors: Atay
authors: Cicek
authors: C
authors: Gercel-Taylor
authors: Douglas D
authors: DD
authors: Taylor
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002450:Cell Communication; D055354:Exosomes / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D019139:Tumor Escape
chemical_list: D014408:Biomarkers, Tumor